Larimar Therapeutics, Inc.LRMRNASDAQ
Loading
Operating cash flow minus capital expenditures
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-113.29M | -59.0% |
| 2024 | $-71.28M | -112.0% |
| 2023 | $-33.62M | -21.5% |
| 2022 | $-27.67M | +34.8% |
| 2021 | $-42.44M | -0.4% |
| 2020 | $-42.26M | -85.5% |
| 2019 | $-22.78M | +55.8% |
| 2018 | $-51.59M | -17.7% |
| 2017 | $-43.84M | +16.7% |
| 2016 | $-52.63M | - |